Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bioโs Lead Therapy
On Wednesday, William Blair initiated coverage of Zura Bio Limited (NASDAQ:ZURA) with an Outperform rating, citing the potential of its lead โฆ
Read from Source ยท benzinga.com ↗
This content is automatically aggregated. Full credit goes to the original publisher (benzinga.com).
